Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ingenza Ltd. | Contract Pharma

What are you searching for?

Sign in

Search by

Ingenza Ltd.

Ingenza Ltd.

Company Headquarters

Moubray Bld., Edinburgh Technopole, Milton Bridge, Scotland, EH26, GB

Driving Directions Phone: View Phone
View website

Company Description

Boutique CRDMO redefining Drug Substance development through its inGenius® platform. With 20+ years of success we develop high-performing mammalian and microbial bioprocesses optimized for productivity, stability, and scale. Leveraging AI across multiple areas, we enhance and streamline development of biologics and complex small molecules.

Request more information from Ingenza Ltd.

Request more information from Ingenza Ltd.

Categories from Ingenza Ltd.

Analytical Methods Development
Biocatalysis
Biologics Manufacturing
Biologics Process Development
Cell Line Construction & Development
Chiral Separations, R&D
CMC (Chemistry, Manfacturing & Controls)
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Research
Custom Manufacturing
Custom Synthesis
Downstream Processing
Endotoxin Testing & Removal
Feasibility Studies
Fermentation
High Throughput Screening
HPLC
Mammalian Cell Culture
Manufacturing, Biologics
Manufacturing, Custom
Manufacturing, Microbial-based Therapeutic Proteins
Methods Development
Microbial Fermentation
Process Characterization
Process Development/Scale-Up Services
Process R&D
Protein Extraction/Purification
Purification
R&D Services
Stability Studies
Technology Transfer

Content From Ingenza Ltd.

Redefining Drug Development with the inGenius™ Platform

Sponsored Content

Redefining Drug Development with the inGenius™ Platform

In this webinar, Dr. Rita Cruz will introduce Ingenza’s inGenius™ platform, which plays a pivotal role in speeding up a candidate’s journey to the clinic.

Released By Ingenza Ltd.

Improve Biopharmaceutical Fermentation With An Innovative, Collaborative Approach

White Papers / Tech Papers

Improve Biopharmaceutical Fermentation With An Innovative, Collaborative Approach

Process development is a crucial stage in biopharmaceutical manufacturing.

Released By Ingenza Ltd.

Related Content

Breaking News

AustinPx KinetiSol Earns FDA AMT Designation

Solvent-free technology expands manufacturing options for poorly soluble oral drug candidates.

By: Charlie Sternberg

Breaking News

Astoriom Acquires Roylance Stability Storage and Roylance Scientific

Acquisition expands Astoriom’s specialist sample storage and biorepository capabilities in the UK.

By: Charlie Sternberg

Breaking News

Sanner Rebrands Gilero, Expands Chicago Facility

North American expansion strengthens CDMO support for medtech and healthcare packaging.

By: Charlie Sternberg

Breaking News

Telix to Buy ITM in $1.65B Radiopharma Deal

The acquisition adds isotope production, manufacturing, and late-stage therapeutic assets to Telix’s radiopharmaceutical platform.

By: Charlie Sternberg

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

Breaking News

Novo Nordisk to Acquire Three Obesity Drug Programs from Kallyope

Deal adds non-incretin obesity assets, including IND-ready peptide candidate K-554, as Novo seeks to broaden its metabolic pipeline.

By: Charlie Sternberg

Collaborations & Alliances

Ori Biotech Lands 10-Year, $120M Commercial Cell Therapy Manufacturing Deal

The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.

By: Patrick Lavery

Collaborations & Alliances

Axiom, GeneFab Partner to Advance Therapeutic Pipeline

The move expands Axiom’s manufacturing and clinical development capabilities.

By: Patrick Lavery

Breaking News

Fareva Expands CDMO Network With Türkiye Site

The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.

By: Charlie Sternberg

Breaking News

Eli Lilly Completes AtaiBeckley Acquisition

Deal adds BPL-003, AtaiBeckley’s lead program for treatment-resistant depression.

By: Charlie Sternberg

Collaborations & Alliances

Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company

The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.

By: Charlie Sternberg

Breaking News

VVMF Sydney Facility Gets Therapeutic Goods Manufacturing License

The company hopes this will expand access to advanced therapeutics manufacturing not only in Australia, but also across Asia-Pacific.

By: Patrick Lavery

Breaking News

CordenPharma Expands Injectable Manufacturing in Italy

The CDMO is adding new property, aseptic fill-finish lines, packaging capacity, and analytical capabilities at its Caponago site near Milan.

By: Charlie Sternberg

Features

Inside the Changing HPAPI Manufacturing Landscape

Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.

By: Charlie Sternberg

Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius

The 3,500-square-meter BIO CITY III facility adds up to 20 cGMP manufacturing lines for cell therapies and personalized medicine.

By: Tim Wright